Hallador Energy Company Reports First Quarter 2025 Financial and Operating Results

1 day ago

– Q1 Total Revenue up 6% YoY to $117.8 Million –– Q1 Net Income up Materially YoY to $10.0 Million or $0.23…

FRP Holdings, Inc. (NASDAQ: FRPH) Announces Results for the First Quarter Ended March 31, 2025

1 day ago

JACKSONVILLE, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- FRP Holdings, Inc. (NASDAQ-FRPH) – FRP Holdings is a real estate asset…

Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

1 day ago

REDWOOD CITY, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company…

VirTra Reports First Quarter 2025 Financial Results

1 day ago

Net Income Rises to $1.3 Million Bookings Up 120% Year Over Year to $6.4 Million CHANDLER, Ariz., May 12, 2025…

Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

1 day ago

Clinical data on track for Q4 2025 from Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLCExpansion…

Oncocyte Reports Q1 2025 Results and Business Progress

1 day ago

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected…

Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights

1 day ago

Announced Boehringer Ingelheim strategic collaboration and license agreement for CUE-501, including an upfront payment of $12 million and ~$345 million…

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for AVMAPKI™FAKZYNJA™ CO-PACK

1 day ago

LOUISVILLE, Ky., May 12, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a…

Beyond Oil Announces Exercise of Warrants and Purchase of Warrant Shares by Clal Insurance

1 day ago

Beyond Oil Receives C$2.166M in Warrant Exercise Proceeds from 1,836,766 WarrantsVANCOUVER, BC and KIBBUTZ YIFAT, Israel, May 12, 2025 (GLOBE…

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

1 day ago

Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to…

This website uses cookies.